HEDIS® Results

Medicaid HEDIS® Annual Rates.

Senior Whole Health’s scores for the past year are below. You can see how Senior Whole Health performs compared to our target goal.

Measure

2022

Goal

Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA)

NA

64.52%

Annual Dental Visits (ADV) Total

NA

53.67%

Antidepressant Medication Management (AMM)

Effective Continuation Phase Treatment

NA

46.09%

Appropriate Testing for Pharyngitis (CWP)

NA

74.02%

Appropriate Treatment for Upper Respiratory Infection (URI) Total

NA

92.46%

Asthma Medication Ratio (AMR) Total

NA

68.21%

Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB)

NA

58.74%

Breast Cancer Screening (BCS)

62.63%

53.96%

Cervical Cancer Screening (CCS)

NA

60.83%

Childhood Immunization Status (CIS) Combination #10

NA

39.42%

Chlamydia Screening in Women (CHL) Total

NA

60.24%

Comprehensive Diabetes Care (CDC) BP Control < 140/90

56.61%

65.21%

Comprehensive Diabetes Care (CDC) HbA1c Control < 8.0%

68.25%

52.80%

Comprehensive Diabetes Care (CDC) Eye Exam

52.38%

54.74%

Controlling High Blood Pressure (CBP)

47.69%

63.50%

Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD)

NA

81.21%

Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total

NA

16.16%

Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total

NA

45.35%

Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total

NA

42.75%

Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) 7-Day Follow-Up Total

NA

37.86%

Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase

NA

55.40%

Immunizations for Adolescents (IMA) Combination #2

NA

39.16%

Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Total

NA

16.57%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Total

NA

39.29%

Pharmacotherapy for Opioid Use Disorder (POD) Total

NA

33.15%

Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids

NA

74.76%

Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator

NA

87.83%

Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio 18-64 Years

NA

≤ 94.44%

Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care

NA

87.83%

Prenatal and Postpartum Care (PPC) Postpartum Care

NA

80.00%

Prenatal Immunization Status (PRS) Combination Rate

NA

27.32%

Risk of Continued Opioid Use (COU) 31-Day Total

3.33%

≤ 2.35%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total

NA

82.29%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total

NA

73.75%

Statin Therapy for Patients with Diabetes (SPD) Received Statin Therapy

90.09%

68.32%

Statin Therapy for Patients with Diabetes (SPD) Statin Adherence 80%

17.00%

70.00%

Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total

NA

65.63%

Use of Imaging Studies for Low Back Pain (LBP)

NA

76.82%

Use of Opioids at High Dosage (HDO)

NA

≤ 2.65%

Use of Opioids from Multiple Providers (UOP) Multiple Prescribers and Multiple Pharmacies

0%

≤ 0.90%

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile

NA

82.73%

 

NA = Not Available Due to Small Denominator
NB = No Benefit
NR = Not Reported
NQ = Not Required
BR = Biased Rate